Saint Louis University

 

sdevine1@slu.edu
Office: (314) 977-9300
3545 Lafayette Ave, Suite #2612, Salus Center
St. Louis, MO 6310

EDUCATION
B.S. University of Houston College of Pharmacy     

MPH Columbia University Mailman School of Public Health (Health Policy)   

PhD  University of North Carolina School of Public Health (Pharmacoepidemiology)  

Expertise

  • Pharmacoepidemiology
  • Drug Safety
  • Pharmacovigilance
  • Database Design
  • Health Policy  

 SLUCOR COURSES

  • ORES 540 Pharmacoeconomics

  • ORES 526 Pharmacoepidemiology

Scott Devine, PhD, BPharm, MPH
Assistant Professor, Center for Outcomes Research
Assistant Professor, Health Management & Policy

Dr. Scott Devine is an expert in drug safety and pharmacoepidemiology. His research interests include the methodologies for creating complex and informative disease definitions through using automated healthcare databases, peri-natal epidemiology, propensity score modeling, implementation of survival analysis techniques and the use of large automated healthcare databases for drug evaluation and pharmacovigilance research.

Scott holds a Bachelor of Science in Pharmacy degree from the University of Houston School of Pharmacy, a Master of Public Health degree from the Columbia University Mailman School of Public Health, and a Doctor of Philosophy degree in Epidemiology from University of North Carolina School of Public Health. Following his doctoral training, he completed a post-doctoral fellowship with the US Food and Drug Administration's Office of Safety and Evaluation with which he still maintains research collaborations.

Scott has been in involved in the delivery of healthcare and healthcare research for over 15 years. He has worked as a hospital, retail and long-term care pharmacist, and most recently as the Director of Health Outcomes Research for Express Scripts. He has also served as a Regional Outcomes Research Scientist for Pfizer. Scott is married to Julie and they have two sons, Adam and Josh. They currently live in St Louis, MO. In his spare time Scott is an avid photographer who is always on the look out for a great picture. 

Selected Publications or Presentations

  1. Vlahiotis A, Devine S, Eicholtz J, Kautzner A; Discontinuation Rates and Healthcare Costs in Patients Starting Brand and Generic SSRIs and SNRIs. Under Review August 2010.
  2. Devine ST, Anderson D, Ford K, Kaye K; Clinical Benefits Associated With Alternative Strategies of Antimicrobial Prophylaxis For Prevention of Surgical Site Infections: A Decision
    Analytic Model. J Pharm Infection Control and Hospital Epidemiology. 2010.
  3. Lane MA, Devine ST, McDonald JR. High Risk Antimicrobial Use in Ambulatory Patients on Warfarin. J Clin Pharm Ther.  2011 Apr 24.
  4. Devine ST, Vlahiotis, A, Sundar, H. Diabetes medication adherence and healthcare costs in patients using mail order pharmacy. J Med Econ. 2010 Jun;13(2):203-11
  5. Sedjo, RL, Devine, ST. Predictors of Non-Adherence to Aromatase Inhibitors among Commercially Insured Women with Breast Cancer J Clin Oncology. Breast Cancer Research
    May 22, 2010 
  6. Devine S, Barron J, Behm A, Weisbart E. Acute epilepsy exacerbations in patients switched between A-rated anti-epileptic drugs. Curr Med Res Opin. 2010 Feb;26(2):455-63.
  7. Devine ST, West S, Hammad, T, Andrews E, Tennis P, Eaton S, Thorp J, Olshan A. Validation of pregnancy identification algorithm within the General Practice Research Database.
    Pharmacoepidemiology and Drug Safety. 2009, Oct 12 
  8. Devine ST, West S, Andrews E, Tennis P, Eaton S, Thorp J, Olshan A. Validation of Neural Tube Defects in the General Practice Research Database. Pharmacoepidemiology and Drug
    Safety. 2008 May; 17(5):434-44.
  9. Przemyslaw K, Devine S, Golembesky A, Roberts C. A Systematic Review and Meta-Analysis of Misuse of Antibiotic Therapies in the Community. Int J Antimicrob Agents. 2005
    Aug;26(2):106-13.
  10. Ramsdell JW, Braunstein SN, Stephens JM, Bell CF, Botteman MF, Devine ST. Economic model of first-line drug strategies to achieve recommended glycaemic control in newly
    diagnosed type 2 diabetes mellitus. Pharmacoeconomics. 2003;21(11):819-37.

Professional Memberships

Academy Health
International Society for Pharmacoepidemiology and Outcomes Research

 American Public Health Association